Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators

8-oxy-quinoline derivatives as bradykinin B2 receptor modulators

US Patent 8410134 · Granted Apr 2, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds comprising a fibroblast activation protein ligand and use thereof2025
Compounds comprising a fibroblast activation protein ligand and use thereof2025
(R)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl2025
1-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)met2025
Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Bradykinin B2 receptor antagonists2023
TFPI inhibitors and methods of use2023
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors2023
Bradykinin B2 receptor antagonists2022
[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Benzimidazole compounds and derivatives as EGFR inhibitors2021